ClinicalTrials.gov
ClinicalTrials.gov Menu

Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected Adults in Senegal

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00100568
Recruitment Status : Completed
First Posted : January 4, 2005
Last Update Posted : September 6, 2013
Sponsor:
Collaborator:
Initiative Senegalaise d'Acces aux Antiretroviraux (ISAARV)
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)